Oliver Bohnsack
23 works · 3,411 citations · h-index 5
Top works
- Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria
- Adaptation of the Immune Related Response Criteria: Irrecist
- Adaptation and modification of the immune related response criteria (IRRC): IrRECIST.
- Comparison of tumor assessments using RECIST 1.1 and irRECIST, and association with overall survival
- Radiologische Evaluation des Tumoransprechens in onkologischen Therapiestudien (Tumor Response Evaluation)
- Reduktion der Strahlenexposition bei CT-Fluoroskopie-gesteuerten Interventionen: Möglichkeiten und Grenzen einer segmentalen Röhrenabschaltung
- RDI as a method for reviewer performance monitoring in BICR setup for improving data quality.
- Value of assessing liver enlargement as a group a parameter in chronic lymphocytic leukemia (CLL) clinical trials: Retrospective review of data from multiple trials for incidence of liver enlargement and impact on response assessment.
- Retrospective comparison of Cheson 2007 and Lugano classification criteria in independent review assessment of FDG-avid lymphomas.
- Challenges with the ODAC-proposed independent audit of site investigator assessments.
- Comparison of response using mRECIST versus RECIST 1.1 Criteria in advanced hepatocellular carcinoma: A retrospective analysis of multicenter clinical trials.
- 168P Response assessments in hepatocellular carcinoma: What are the best criteria to utilize? mRECIST or RECIST 1.1? A retrospective meta-analysis of multiple phase III trials
- Radiologische Evaluation des Tumoransprechens in onkologischen Therapiestudien (Tumor Response Evaluation)
- CCR Translation for the Article from Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria
- Data from Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria
- Identification of new lesion with disease progression in Ovarian cancer per RECIST 1.1.
- CCR Translation for the Article from Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria
- Imaging determinants of early progression in relapsed and refractory Hodgkin and diffuse large B cell lymphoma.
- Bruton tyrosine kinase inhibitors (BTKi) therapies in chronic lymphocytic leukemia (CLL): Review of multiple trials data for incidence of lymphocytosis and designation of partial response with lymphocytosis (PRL).
- Data from Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria